nyra health, a Vienna, Austria-based provider of an AI-based platform for neurological therapy, has raised €20 million in Series A funding. 

Investors

The round was led by Armira Growth, with participation from existing investors Wellington Partners, Crane Venture Partners, and EVER Pharma. 

Armira is a European investment holding specializing in partnerships with entrepreneur-led and family-owned hidden champions with a long-term horizon. The firm provides full-lifecycle capital, ranging from minority growth investments to majority positions. Managing over €5 billion in assets, Armira is backed by a broad base of entrepreneurs, entrepreneurial families, and long-term-oriented investors. 

nyra health Use of Funds 

The company will use the funds to expand its technology platform across the DACH region, support entry into the U.S. market, and advance multimodal AI models for neurorehabilitation. 

About nyra health 

nyra health is a healthcare technology company that provides an AI-powered platform for neurological rehabilitation. The platform includes the CE-certified therapy software myReha (MDR Class IIa) and the clinical management system nyra insights. It is currently used in more than 100 rehabilitation clinics, in the digital rehabilitation aftercare program of the German Pension Insurance Fund, and by patients, with support from over 28 health insurance companies. The company is certified according to ISO 13485 and ISO 27001 standards and has published eleven scientific papers in clinical and technological journals. 

Funding Details 

Company: nyra health GmbH 

Raised: $21.6M 

Round: Series A 

Funding Date: March 2026 

Lead Investor: Armira Growth 

Additional Investors: Wellington Partners, Crane Venture Partners, EVER Pharma 

Company Website: https://www.nyra.health/  

Software Category: AI Healthcare / Neurorehabilitation 

Source: nyra health